- Rising Pharmaceuticals, a wholly-owned subsidiary of ACETO Corp. (ACET), signs a definitive purchase agreement to acquire PACT Pharmaceuticals, a marketer and distributor of generic prescription and OTC products.
- The cash-and-stock deal is worth $100M. The initial payment is $80M in cash and $5M in ACETO stock. Earn-outs total $15M based on achieving certain performance-based targets over the next three years.
- The acquisition will enable the firm to expand further into the finished dosing drug business.
ACETO unit buys generic drug distributor
From other sites
at Nasdaq.com (Mar 9, 2015)
at CNBC.com (May 30, 2014)
at CNBC.com (Sep 6, 2013)
at MarketWatch.com (Sep 6, 2012)
at CNBC.com (Mar 30, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs